Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET

Journal of the Neurological Sciences

Volumn 255, Issue 1-2, 2007, Pages 17-22

  Johansson, Anders ^a   Engler, Henry ^b   Blomquist, Gunnar ^c   Scott, Berit ^c   Wall, Anders ^b   Aquilonius, Sten Magnus ^a   Långström, Bengt ^b   Askmark, Håkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Uppsala Imanet   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

ALS; Amyotrophic lateral sclerosis; Astrocytosis; Deprenyl; MAO B; Motor neuron disease; PET

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBON 11; CITALOPRAM; DEUTERIUM; DIAZEPAM; ISOTOPE; ORAL CONTRACEPTIVE AGENT; OXAZEPAM; PROPRANOLOL; RILUZOLE; SELEGILINE; SIMVASTATIN; VERAPAMIL; ZOLPIDEM; ZOPICLONE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BOLUS INJECTION; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG BINDING SITE; DRUG UPTAKE; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; PONS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; WHITE MATTER; WHOLE BODY SCANNER;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTES; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; DEUTERIUM; FEMALE; GLIOSIS; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; NERVE FIBERS, MYELINATED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; SELEGILINE;

EID: 33947201570     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.057     Document Type: Article

References (42)

1. Kamo H., Haebara H., Akiguchi I., Kameyama M., Kimura H., and McGeer P.L. A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 74 1 (1987) 33-38
2. Kushner P.D., Stephenson D.T., and Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 50 3 (1991) 263-277
3. Schiffer D., Cordera S., Cavalla P., and Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 139 (1996) 27-33 (Suppl)
4. Silani V., Ciammola A., Pizzuti A., Cardin V., and Scarlato G. Motor neurone metabolism. J Neurol Sci 169 1-2 (1999) 161-169
5. Barbeito L.H., Pehar M., Cassina P., Vargas M.R., Peluffo H., Viera L., et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 47 1-3 (2004) 263-274
6. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 5642 (2003) 113-117
7. Levine J.B., Kong J., Nadler M., and Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 28 3 (1999) 215-224
8. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185 2 (2004) 232-240
9. Oreland L., Fowler C.J., Carlsson A., and Magnusson T. Monoamine oxidase-A and -B activity in the rat brain after hemitransection. Life Sci 26 2 (1980) 139-146
10. Levitt P., Pintar J.E., and Breakefield X.O. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci U S A 79 20 (1982) 6385-6389
11. Nakamura S., Kawamata T., Akiguchi I., Kameyama M., Nakamura N., and Kimura H. Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol (Berl) 80 4 (1990) 419-425
12. Jossan S.S., Gillberg P.G., d'Argy R., Aquilonius S.M., Langstrom B., Halldin C., et al. Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H]deprenyl. Brain Res 547 1 (1991) 69-76
13. Aquilonius S.M., Jossan S.S., Ekblom J.G., Askmark H., and Gillberg P.G. Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography. J Neural Transm Gen Sect 89 1-2 (1992) 111-122
14. Ekblom J., Jossan S.S., Bergstrom M., Oreland L., Walum E., and Aquilonius S.M. Monoamine oxidase-B in astrocytes. Glia 8 2 (1993) 122-132
15. Fowler J.S., MacGregor R.R., Wolf A.P., Arnett C.D., Dewey S.L., Schlyer D., et al. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science 235 4787 (1987) 481-485
16. Fowler J.S., Wang G.J., Logan J., Xie S., Volkow N.D., MacGregor R.R., et al. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping. J Nucl Med 36 7 (1995) 1255-1262
17. Fowler J.S., Logan J., Volkow N.D., Wang G.J., MacGregor R.R., and Ding Y.S. Monoamine oxidase: radiotracer development and human studies. Methods 27 3 (2002) 263-277
18. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124 (1994) 96-107 (Suppl)
19. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 53 2 (1996) 141-147
20. Engler H., Lundberg P.O., Ekbom K., Nennesmo I., Nilsson A., Bergstrom M., et al. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease. Eur J Nucl Med Mol Imaging 30 1 (2003) 85-95
21. Patlak C.S., and Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5 4 (1985) 584-590
22. Blomqvist G., Engler H., Wall A., and Långström B. Graphical analysis of time-activity data using a reference region with known irreversible binding. In: Knuuti J., and Någren K. (Eds). ANNALES UNIVERSITATIS TURKUENSIS Ser. D: Medica - Odontologica. Turku PET Symposium. Abstracts of the IX Turku PET Symposium, May 25-28, 2002, Turku, Finland vol. 499 (2002), Turku University 120
23. Lundquist P., Blomquist G., Hartvig P., Hagberg G.E., Torstenson R., Hammarlund-Udenaes M., et al. Validation studies on the 5-hydroxy-L-[beta-11C]-tryptophan/PET method for probing the decarboxylase step in serotonin synthesis. Synapse 59 8 (2006) 521-531
24. Ekblom J., Jossan S.S., Gillberg P.G., Oreland L., and Aquilonius S.M. Monoamine oxidase-B in motor cortex: changes in amyotrophic lateral sclerosis. Neuroscience 49 4 (1992) 763-769
25. Fowler J.S., Volkow N.D., Wang G.J., Logan J., Pappas N., Shea C., et al. Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging 18 4 (1997) 431-435
26. Cumming P., Yokoi F., Chen A., Deep P., Dagher A., Reutens D., et al. Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse 34 2 (1999) 124-134
27. Fowler J.S., Volkow N.D., Logan J., Wang G.J., MacGregor R.R., Schyler D., et al. Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal. Synapse 18 2 (1994) 86-93
28. Kew J.J., Leigh P.N., Playford E.D., Passingham R.E., Goldstein L.H., Frackowiak R.S., et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 116 Pt 3 (1993) 655-680
29. Hirata M., Kagawa S., Yoshimoto M., and Ohmomo Y. Synthesis and characterization of radioiodinated MD-230254: a new ligand for potential imaging of monoamine oxidase B activity by single photon emission computed tomography. Chem Pharm Bull (Tokyo) 50 5 (2002) 609-614
30. Buck A., Frey L.D., Blauenstein P., Kramer G., Siegel A., Weber B., et al. Monoamine oxidase B single-photon emission tomography with [123I]Ro 43-0463: imaging in volunteers and patients with temporal lobe epilepsy. Eur J Nucl Med 25 5 (1998) 464-470
31. Takahashi H., Snow B.J., Bhatt M.H., Peppard R., Eisen A., and Calne D.B. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 342 8878 (1993) 1016-1018
32. Lloyd C.M., Richardson M.P., Brooks D.J., Al-Chalabi A., and Leigh P.N. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 123 Pt 11 (2000) 2289-2296
33. Turner M.R., Hammers A., Al-Chalabi A., Shaw C.E., Andersen P.M., Brooks D.J., et al. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain 128 Pt 6 (2005) 1323-1329
34. Turner M.R., Rabiner E.A., Hammers A., Al-Chalabi A., Grasby P.M., Shaw C.E., et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 128 Pt 4 (2005) 896-905
35. Dalakas M.C., Hatazawa J., Brooks R.A., and Di Chiro G. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol 22 5 (1987) 580-586
36. Ludolph A.C., Langen K.J., Regard M., Herzog H., Kemper B., Kuwert T., et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 85 2 (1992) 81-89
37. Tanaka M., Kondo S., Hirai S., Sun X., Yamagishi T., and Okamoto K. Cerebral blood flow and oxygen metabolism in progressive dementia associated with amyotrophic lateral sclerosis. J Neurol Sci 120 1 (1993) 22-28
38. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [(11)C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15 3 (2004) 601-609
39. Logan J., Fowler J.S., Volkow N.D., Wang G.J., MacGregor R.R., and Shea C. Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain. Nucl Med Biol 27 1 (2000) 43-49
40. Wang S., Poptani H., Bilello M., Wu X., Woo J.H., Elman L.B., et al. Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract. AJNR Am J Neuroradiol 27 6 (2006) 1234-1238
41. Hall E.D., Oostveen J.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 3 (1998) 249-256
42. Rathke-Hartlieb S., Schmidt V.C., Jockusch H., Schmitt-John T., and Bartsch J.W. Spatiotemporal progression of neurodegeneration and glia activation in the wobbler neuropathy of the mouse. Neuroreport 10 16 (1999) 3411-3416